Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On February 9, 2011, the Board of Directors of Bioheart, Inc. (the "Company") appointed Ariel Quiros to serve as a director of the Company.

Mr. Quiros is the President of US operations of AnC Bio Holdings, Inc, a publicly listed company on the Korea Stock Exchange (KS039670) founded in 1999. AnC Bio owns a state of the art cGMP cell culturing facility for stem cell therapies including research, development, and manufacturing of biomedical devices and therapies. Mr. Quiros is also a director and principal of GSI Group, a raw materials procurement company for the South Korean manufacturing community with offices in Seoul, Beijing, Sydney, Hong Kong and Miami.

As disclosed in our current report on 8K filed with the SEC on January 25, 2011, AnC BIO Holdings, Inc., in connection with its purchase of common shares, is entitled to designate a person to fill a Director vacancy on our Board of Directors. Mr. Quiros has been designated as the person to fill the Director vacancy.